Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Mild gastrointestinal symptoms have been reported at higher levels of intake
Without specific proof as to the exact cause of why a GLP-1 could cause a higher risk of developing NAION, we can hypothesize a bit and suggest hypovolemia and dehydration from perhaps weight loss, especially if the patient is getting a medication for hypertension and the weight loss has reduced the need for the hypertensive agent and thus the patient develops hypotension
Semaglutide can delay gastric emptying and may therefore affect the absorption of medications taken at the same time
Based on our research, there is promising potential for GLP-1 RAs and SGLT2is to be considered for Alzheimers disease prevention in the future
Common Side Effects For most patients, gastrointestinal side effects are mild to moderate and improve significantly within the first 48 weeks
